BIOASTER, a new model for technology innovation in microbiology

Expanding creativity, adding value, together. Opening new technology avenues applied to microbiology in health and diseases.

Created in April 2012 by l’Institut Pasteur and Lyonbiopole health competitiveness cluster, following the initiative of the French government, BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to :

Icon protection

Fight antimicrobials resistance.

Icone security

Improve vaccines safety and efficacy.

Icon diagnostic

Quickly diagnose infections at patient bedside.

Icon microbio

Take full advantage to human and animal microbiota.

In a nutshell

In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups.

The institute relies on :

  • Support by French Governmentthrough the “Investissements d’Avenir” Program (grant no. ANR-10-AIRT-03).
  • Infrastructures funded by regional authorities :The Metropolis of Lyon and the Auvergne-Rhône-Alpes Region
  • World-class academics and industries :the Institut Pasteur and Lyonbiopole (co-leaders in BIOASTER creation), CEA, CNRS, Inserm, Danone Nutricia Research, Institut Mérieux and Sanofi Pasteur
  • Support from highly dynamic SMEs from Lyon and Paris area
  • More than 120 employees,coming equally from industries & academics, of which the large majority are scientists and engineers originating from 17 different citizenships
  • Own infrastructures and advanced equipmentsalmost 4,500 m2 split between Lyon and Paris, of which 2,500 m2 is laboratory space
  • Access to state of the art platforms :The CNRS-CC-IN2P3 Centre de Calcul de l’Institut National de Physique Nucléaire et de Physique des Particules (French National Institute of Nuclear and Particle Physics Computing Centre) and the Jean Mérieux BSL4 laboratory in Lyon.